Olaf Hiort Selected Research

Therapeutics

1/2023	Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia.
1/2017	Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When?
2/2012	Satisfaction with genital surgery and sexual life of adults with XY disorders of sex development: results from the German clinical evaluation study.
1/2012	Disorders of sex development and hypogonadism: genetics, mechanism, and therapies.
4/2010	46,XY disorders of sex development--the undermasculinised male with disorders of androgen action.
3/2007	Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
10/2003	Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olaf Hiort Research Topics

Disease

23	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2022 - 01/2003
13	Pseudohypoparathyroidism 01/2020 - 04/2003
10	Disorders of Sex Development (Intersexuality) 02/2022 - 02/2002
8	Virilism (Virilization) 02/2022 - 02/2002
8	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 01/2019 - 08/2005
6	Hypogonadism (Hypergonadotropic Hypogonadism) 12/2022 - 01/2012
5	Hypospadias 01/2022 - 01/2004
4	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2023 - 10/2003
4	Rickets (Rachitis) 01/2023 - 10/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 03/2007
4	Hypocalcemia 11/2011 - 09/2008
3	Obesity 01/2020 - 01/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 08/2023 - 11/2020
2	Congenital Abnormalities (Deformity) 01/2023 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023 - 01/2017
2	Cryptorchidism (Undescended Testes) 01/2022 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Brachydactyly 01/2020 - 01/2010
2	Pseudopseudohypoparathyroidism 03/2015 - 04/2003
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 08/2014 - 07/2008
2	Hyperphosphatemia 01/2011 - 09/2008
1	Neurodevelopmental Disorders 04/2023
1	Anorchia 04/2023
1	46,XY Gonadal Dysgenesis (Swyer Syndrome) 04/2023
1	Epistaxis (Nosebleed) 01/2023
1	Cerebrospinal Fluid Leak 01/2023
1	Hypophosphatemia 01/2023
1	Inappropriate ADH Syndrome (SIADH) 01/2023
1	Diabetes Insipidus 01/2023
1	Hypopituitarism (Sheehan's Syndrome) 01/2023
1	Primary Ovarian Insufficiency 12/2022
1	Chronic Disease (Chronic Diseases) 06/2022
1	Inflammation (Inflammations) 01/2021
1	Hypothyroidism 01/2020
1	Mixed Gonadal Dysgenesis 01/2019
1	Endocrine System Diseases (Endocrine Diseases) 12/2018
1	Chronic Renal Insufficiency 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Hypercalcemia (Milk Alkali Syndrome) 01/2018
1	Nephrocalcinosis 01/2018
1	Glucose Intolerance 01/2018
1	Weight Gain 01/2018
1	Birth Weight (Birth Weights) 03/2017
1	Neoplasms (Cancer) 01/2017
1	Amenorrhea 01/2017
1	Penis agenesis 09/2015
1	Gonadal Dysgenesis (Gonadal Agenesis) 01/2015
1	Gynecomastia 01/2014
1	Male Infertility (Male Sterility) 01/2014
1	Gender Dysphoria 11/2013
1	Acrodysostosis 12/2012
1	Feminization 02/2012

Drug/Important Bio-Agent (IBA)

23	AndrogensIBA 01/2023 - 06/2005
16	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2003
12	Testosterone (Sustanon)FDA Link 02/2022 - 02/2002
8	Parathyroid Hormone (Parathormone)IBA 01/2020 - 04/2005
8	SteroidsIBA 01/2019 - 02/2002
8	Hormones (Hormone)IBA 03/2017 - 02/2003
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2003
4	Growth Hormone (Somatotropin)IBA 01/2020 - 03/2017
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2020
3	Insulin (Novolin)FDA Link 08/2023 - 03/2007
3	GonadotropinsIBA 01/2022 - 01/2015
3	Parathyroid Hormone-Related ProteinIBA 01/2018 - 03/2010
3	EnzymesIBA 09/2015 - 02/2002
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2012 - 06/2011
3	Dihydrotestosterone (Androstanolone)IBA 08/2005 - 02/2002
2	Prostaglandins DIBA 04/2023 - 01/2019
2	Phosphates (Orthophosphate)IBA 01/2023 - 11/2020
2	Apolipoproteins D (Apo D)IBA 10/2019 - 06/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2013
2	inhibin BIBA 01/2015 - 08/2009
2	GTP-Binding Proteins (G-Protein)IBA 08/2014 - 06/2011
2	1,25-dihydroxyvitamin DIBA 11/2011 - 10/2003
2	IsoenzymesIBA 01/2010 - 01/2004
2	CalciumIBA 01/2009 - 04/2003
1	RNA Helicases (RNA Helicase)IBA 04/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	MineralsIBA 01/2023
1	Thymidine Monophosphate (TMP)IBA 01/2023
1	Vasopressins (Vasopressin)IBA 01/2023
1	burosumabIBA 01/2023
1	SDMIBA 12/2022
1	Nimodipine (Modus)FDA LinkGeneric 06/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	SolutionsIBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 01/2018
1	5' Untranslated Regions (5' UTR)IBA 01/2016
1	5-phenylpent-4-enyl-1-hydroperoxideIBA 03/2015
1	amsonic acid (DAS)IBA 09/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2011
1	steroidogenic acute regulatory proteinIBA 01/2011

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2003
4	Castration 01/2023 - 02/2012
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2018
1	Orthopedic Procedures 01/2018